Kongressdetails

We live in exciting times – gene therapies for specific neurological diseases and ketogenic dietary therapies for Glut1 Deficiency Syndrome (Glut1DS), termed „precision medicine“ are advancing. Thirty years of Glut1DS have brought large insights in disease mechanisms, diagnosis and clinical manifestions, and treatment of this entity. Diets have become more accessible and flexible, guidelines and ketogenic products are increasingly available. Patients, family groups,and clinicians share information and support research.